Position in DNLI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,819,814
New position
Shares Held
94,782
first reported quarter
Ownership
0.060%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Lumbard & Kellner, LLC holds $1,987,130 across 2 Biotechnology names. DNLI ranks #1 (91.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DNLI |
Denali Therapeutics Inc.
This page
|
94,782 | $1,819,814 | |
| 2 | PYPD |
PolyPid Ltd.
|
38,200 | $167,316 |
All Filings in DNLI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,819,814 | 94,782 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||